Tuesday Pre-Market Insights: THLD, PLL, AOL, CALL

May 12, 2015

Threshold Pharmaceuticals, Inc. (THLD) increased more than 26% in pre-market trading to $4.76 after the pharmaceutical company announced that TH-302 received FDA fast-track designation. The pancreatic cancer drug is being produced in partnership with Merck.

Pall Corporation (PLL) rose 20% to $119.17 per share following news that potential buyers are looking to buy the company. The water-filtration producer is valued at over $10 billion and is being courted by Danaher Corp and Thermo Fisher Scientific.

AOL, Inc. (AOL) shares are up more than 18% to over $50 per share after Verizon confirmed plans to buy the company for $4.4 billion, valued at $50 per share. The deal will include AOL subsidiaries; Huffington Post and Techcrunch.

magicJack VocalTec Ltd (CALL) shares increased over 18% in pre-market trading to $8.30 a share after the company reported first quarter earnings. The cloud communications company beat the EPS estimate of $0.23 by $0.08 and posted revenue of $25.5 million for the quarter.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.